Lifeboat Foundation

Analyzed the global trends in this area of neuroscience. To identify and further facilitate the development of cerebral organoids, we utilized bibliometrics and visualization methods to analyze the global trends and evolution of brain organoids in the last 10 years. First, annual publications, countries/regions, organizations, journals, authors, co-citations, and keywords relating to brain organoids were identified. The hotspots in this field were also systematically identified. Subsequently, current applications for brain organoids in neuroscience, including human neural development, neural disorders, infectious diseases, regenerative medicine, drug discovery, and toxicity assessment studies, are comprehensively discussed.

Organoids are carefully grown collections of cells in a dish, designed to mimic organ structures and composition better than conventional cell cultures and give researchers a unique view into how organs such as the brain grow and develop. To make them experimentally useful, scientists need to determine how faithfully these models reproduce the behavior of cells in the body.

Now, researchers at the Broad Institute of MIT and Harvard and Harvard University have found that human brain organoids replicate many important cellular and molecular events of the developing human cortex, the part of the brain responsible for movement, perception, and thought. Their findings appear today in Cell.

The team grew brain organoids from stem cells and closely studied their growth over a six-month period, using tools that map cell position, gene expression, and chromatin accessibility — which determines how gene activity is regulated — at a single-cell level and over time. They then constructed an “atlas” characterizing more than 600,000 cells from organoids that were sampled as they developed and matured. The team found that after the first month, in each organoid they made, the same types of cells developed in the same order and expressed the same genes as cells in the developing human embryo.

The dramatic advances in efferent neural interfaces over the past decade are remarkable, with cortical signals used to allow paralyzed patients to control the movement of a prosthetic limb or even their own hand. However, this success has thrown into relief, the relative lack of progress in our ability to restore somatosensation to these same patients. Somatosensation, including proprioception, the sense of limb position and movement, plays a crucial role in even basic motor tasks like reaching and walking. Its loss results in crippling deficits. Historical work dating back decades and even centuries has demonstrated that modality-specific sensations can be elicited by activating the central nervous system electrically. Recent work has focused on the challenge of refining these sensations by stimulating the somatosensory cortex (S1) directly. Animals are able to detect particular patterns of stimulation and even associate those patterns with particular sensory cues. Most of this work has involved areas of the somatosensory cortex that mediate the sense of touch. Very little corresponding work has been done for proprioception. Here we describe the effort to develop afferent neural interfaces through spatiotemporally precise intracortical microstimulation (ICMS). We review what is known of the cortical representation of proprioception, and describe recent work in our lab that demonstrates for the first time, that sensations like those of natural proprioception may be evoked by ICMS in S1. These preliminary findings are an important first step to the development of an afferent cortical interface to restore proprioception.

Keywords: Intracortical microstimulation (ICMS); Prosthesis; Somatosensation; Somatosensory cortex.

PubMed Disclaimer

Remarks by David Chalmers in a memorial session for Daniel Dennett, at ASSC 27 (the 27th meeting of the Association for the Scientific Study of Consciousness) in Tokyo on July 3, 2024. Filmed by Van Royko and Marie-Philippe Gilbert for EyeSteelFilm.

Check out the Space Time Merch Store https://www.pbsspacetime.com/shopSign Up on Patreon to get access to the Space Time Discord!https://www.patreon.com/pbssp…

In a recent study published in Neuron, researchers discovered that microglia, the brain’s immune cells, use tunneling nanotubes…

Scheiblich et al. uncover a novel mechanism by which microglia use tunneling nanotubes to connect with α-syn-or tau-burdened neurons, enabling transfer of these proteins to microglia for clearance. Microglia donate mitochondria to restore neuronal health, shedding light on new therapeutic strategies for neurodegenerative diseases.

Nano-MIND Technology for Wireless Control of Brain Circuits with Potential to Modulate Emotions, Social Behaviors, and Appetite.

Researchers at the Center for Nanomedicine within the Institute for Basic Science (IBS) and Yonsei University in South Korea have unveiled a groundbreaking technology that can manipulate specific regions of the brain using magnetic fields, potentially unlocking the secrets of high-level brain functions such as cognition, emotion, and motivation. The team has developed the world’s first Nano-MIND (Magnetogenetic Interface for NeuroDynamics) technology, which allows for wireless, remote, and precise modulation of specific deep brain neural circuits using magnetism.

The human brain contains over 100 billion neurons interconnected in a complex network. Controlling the neural circuits is crucial for understanding higher brain functions like cognition, emotion, and social behavior, as well as identifying the causes of various brain disorders. Novel technology to control brain functions also has implications for advancing brain-computer interfaces (BCIs), such as those being developed by Neuralink, which aim to enable control of external devices through thought alone.

Continue reading “New Technology to Control the Brain Using Magnetic Fields Developed” »

A loss of controlled inhibition of overly excited brain cells might explain how a common knock-out anesthesia drug works.

A new animal study led by researchers from the Massachusetts Institute of Technology (MIT) has found that propofol, a sedative used to safely lull people into unconsciousness for medical procedures, disrupts the brain’s normal ability to regain control of highly excitable neurons.

“The brain has to operate on this knife’s edge between excitability and chaos,” explains MIT neuroscientist and senior study author Earl Miller.

Minimally invasive cellular-level target-specific neuromodulation is needed to decipher brain function and neural circuitry. Here nano-magnetogenetics using magnetic force actuating nanoparticles has been reported, enabling wireless and remote stimulation of targeted deep brain neurons in freely behaving animals.